Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12060390 Antibody-evading virus vectors

Patent 12060390 was granted and assigned to Ginkgo Bioworks on August, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Current Assignee

Ginkgo Bioworks

Date Filed

September 26, 2023

Date of Patent

August 13, 2024

Patent Applicant

Ginkgo Bioworks

Patent Application Number

18372823

Patent Citations

‌

US Patent 7198951 Adeno-associated virus (AAV) serotype 9 sequences, vectors containing same, and uses therefor

‌

US Patent 7201898 Methods and compounds for controlled release of recombinant parvovirus vectors

‌

US Patent 7214786 Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement

‌

US Patent 7252997 Structural protein of adeno-associated virus with modified antigenicity, its production and its use

‌

US Patent 7259151 AAV virions with decreased immunoreactivity and uses therefor

‌

US Patent 7282199 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

‌

US Patent 7314912 AAv scleroprotein, production and use thereof

‌

US Patent 7473531 Pancreatic cancer targets and uses thereof

‌

US Patent 7588772 AAV capsid library and AAV capsid proteins

‌

US Patent 7712893 Jewelry article for a lens of eyeglasses and a jewelry-installation tool for a pair of eyeglasses

•••

Patent Inventor Names

Daniel McCoy

Garrett E. Berry

James Kennon Smith

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

12060390

Patent Primary Examiner

CPC Code

Find more entities like US Patent 12060390 Antibody-evading virus vectors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.